Related Experiment Video
Updated: May 28, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
C Hiemke1, P Baumann, N Bergemann
1Department of Psychiatry and Psychotherapy.
Pharmacopsychiatry
|October 5, 2011
Summary
Therapeutic drug monitoring (TDM) optimizes psychopharmacotherapy by measuring drug levels. Updated AGNP guidelines provide recommendations for 128 drugs, aiding clinicians in patient-matched treatment and improving outcomes.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Pharmacogenomics
Background:
- Therapeutic drug monitoring (TDM) is crucial for optimizing psychopharmacotherapy, especially in specific patient groups.
- Current clinical practice requires updated guidelines due to advancements in psychopharmacology and TDM methods.
- Previous AGNP guidelines from 2004 need revision to incorporate new drugs and evidence.
Purpose of the Study:
- To update and extend the AGNP guidelines for TDM in psychiatry.
- To provide evidence-based recommendations for the use of TDM in clinical practice.
- To enhance the optimization of psychopharmacotherapy through improved TDM integration.
Main Methods:
- Extensive literature search and structured internal review process.
- Updated consensus guidelines covering 128 neuropsychiatric drugs.
- Defined 4 levels of recommendation for TDM use, from 'strongly recommended' to 'potentially useful'.
Main Results:
- Established evidence-based 'therapeutic reference ranges' and 'dose-related reference ranges'.
- Introduced a 'laboratory alert level' for immediate physician notification.
- Included supportive information on CYP450 interactions, metabolite-to-parent drug ratios, and pharmacogenetic testing integration.
Conclusions:
- Updated AGNP guidelines facilitate appropriate TDM use for improved psychopharmacotherapy outcomes.
- TDM, when integrated with clinical practice and potentially pharmacogenetics, benefits patients with pharmacokinetic challenges.
- TDM is an interdisciplinary effort requiring collaboration for optimal patient benefit.
Related Concept Videos
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...